HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $228,834 | -38.0% | 5,992 | -7.6% | 0.01% | -54.5% |
Q4 2022 | $368,826 | +44.1% | 6,482 | +0.2% | 0.01% | +22.2% |
Q3 2022 | $256,000 | +0.8% | 6,466 | +12.2% | 0.01% | -18.2% |
Q2 2022 | $254,000 | +10.9% | 5,765 | +0.3% | 0.01% | +22.2% |
Q1 2022 | $229,000 | -0.9% | 5,750 | 0.0% | 0.01% | +12.5% |
Q4 2021 | $231,000 | +13.8% | 5,750 | +15.0% | 0.01% | 0.0% |
Q3 2021 | $203,000 | -11.7% | 5,000 | -1.1% | 0.01% | -11.1% |
Q2 2021 | $230,000 | -12.9% | 5,055 | -20.0% | 0.01% | -25.0% |
Q1 2021 | $264,000 | +14.8% | 6,321 | +17.3% | 0.01% | 0.0% |
Q4 2020 | $230,000 | – | 5,387 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |